This whitepaper provides a review of global clinical trials with a start date between 1...
Gene therapy involves the delivery of complex treatments to patients. In recent years, there have been several promising clinical trial results within this field targeting an array of inherited neurodegenerative disorders, genetic diseases, and various cancers.
Approvals based on these clinical trials have consequently encouraged interest in gene therapy from both industry and non-industry sponsors, and have boosted confidence in the therapeutic delivery of genetic material. This white paper investigates the changing clinical trial landscape for gene therapy clinical trials.
The data for these analyses are derived from GlobalData’s clinical trials module on the Pharma Intelligence Center and include gene therapy clinical trials initiated from 1 January 1995 to 31 December 2019.